Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
B B B0 B1 B4 B7 B8 BA BB BC BD BE BF BG BH BI BK BL BM BN BO BP BR BS BT BU BV BW BX BY BZ
selected terms: 4,011
 << Prev ▫ 1 ▫ .. ▫ 5 ▫ 6 ▫ 7 ▫ 8 ▫ 9 ▫ 10 ▫ 11 ▫ .. ▫ 41 ▫ Next >>
 page 8 of 41

701. BAVS
(UMLS (NCI) C0279237) =Therapeutic or Preventive Procedure ;
751. BCG 9331
(UMLS (NCI) C0299046) =Organic Chemical; Pharmacologic Substance ;
702. BAX
[The BAX gene produces at least four proteins by alternate splicing: membrane-bound alpha and cytoplasmic beta, gamma, and delta; all bind and antagonize BCL2, which represses programmed cell death. Pro-apoptotic BAX acts as a partner of BCL2, shows extensive homology with BCL2, and forms homodimers and heterodimers with BCL2. Pro-apoptotic BAX and BAK proteins accelerate opening of the mitochondrial porin channel, VDAC. BAX appears to interact, and cooperate, with the constitutive pro-apoptotic ANT mitochondrial protein within the pore complex to increase mitochondrial permeability, allowing cytochrome C passage and triggering cell death. Expression of BAX is a significant prognostic factor in patients with gastric lymphoma. Its prognostic value increases significantly when studied in BCL2-negative patients. (from OMIM 600040 and NCI) ( NCI )] (UMLS (NCI) C0219474) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
752. BCG Tice
(UMLS (NCI) C0307852) =Bacterium ;
703. BAX
[This gene is involved in the regulation of apoptosis by binding p53 protein, which accelerates this mechanism of cell death. ( NCI )] (UMLS (NCI) C0812198) Bax gene;
BCL2-Associated X Protein Gene =Gene or Genome ;
753. BCG/5-FU
(UMLS (NCI) C0280654) =Therapeutic or Preventive Procedure
704. Bax gene/protein
[21 kDa homologous partner of Bcl-2; ratio of Bcl-2 to Bax determines cell survival or death following an apoptotic stimulus. ( CSP )] (UMLS (CSP) C0872019) =Classification ;
=Cellular Oncogene;
754. BCG/CTX/DOX/FT
(UMLS (NCI) C0279358) =Therapeutic or Preventive Procedure
705. Baxarytmon
(UMLS (NCI) C0004847) =Organic Chemical; Pharmacologic Substance ;
755. BCG/CTX/IL-2
(UMLS (NCI) C0279897) =Therapeutic or Preventive Procedure
706. Baxter Health Corporation
(UMLS (HL7) C1546863) Baxter Healthcare Coporation];
=Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
756. BCG/Dacarbazine
(UMLS (NCI) C0338345) =Therapeutic or Preventive Procedure ;
707. Baxter Healthcare Corporation
[Baxter Healthcare Corporation ( HL7V3.0 )] (UMLS (HL7) C1552884) =Health Care Related Organization =VaccineManufacturer;
757. BCG/IL-2
(UMLS (NCI) C0280836) =Therapeutic or Preventive Procedure
708. BAY 12-9566
[An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. ( NCI )] (UMLS (NCI) C0393069) =Organic Chemical; Pharmacologic Substance ;
758. BCG/INH
(UMLS (NCI) C0281144) =Therapeutic or Preventive Procedure
709. BAY 12-9566/DOX
(UMLS (NCI) C0796316) BAY 12-9566/Doxorubicin;
=Therapeutic or Preventive Procedure
759. BCG/Interferon alfa
(UMLS (NCI) C0879369) =Therapeutic or Preventive Procedure ;
710. BAY 12-9566/Fluorouracil/Leucovorin Calcium
(UMLS (NCI) C0796317) =Therapeutic or Preventive Procedure
760. BCG/MITO
(UMLS (NCI) C0280764) =Therapeutic or Preventive Procedure
711. BAY 128039
(UMLS (NCI) C0878537) =Organic Chemical; Pharmacologic Substance
761. BCG/MOAB BEC2
(UMLS (NCI) C0678027) =Therapeutic or Preventive Procedure ;
712. BAY 38-3441
(UMLS (NCI) C1101785) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
762. BCG/Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
(UMLS (NCI) C1134501) =Therapeutic or Preventive Procedure
713. BAY 43-9006
(UMLS (NCI) C1174389) BAY 43-9006 Tosylate;
BAY 54-9085 =Organic Chemical; Pharmacologic Substance ;
763. BCG/NY-ESO-1 Peptide Vaccine
(UMLS (NCI) C1328047) =Therapeutic or Preventive Procedure ;
714. BAY 56-3722
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called camptothecins. ( NCI )] (UMLS (NCI) C1134706) =Pharmacologic Substance ;
764. BCG/Polyvalent Melanoma Vaccine
(UMLS (NCI) C0879365) =Therapeutic or Preventive Procedure ;
715. Bay 59-8862
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called taxanes. ( NCI )] (UMLS (NCI) C1135138) =Organic Chemical; Pharmacologic Substance ;
765. BCH-4556
(UMLS (NCI) C0168829) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
716. Bay g 5421
(UMLS (NCI) C0752276) =Carbohydrate; Pharmacologic Substance
766. BCHE
[This gene plays a role in acylcholine hydrolysis and the regulation of myeloid cells. ( NCI )] (UMLS (NCI) C1412756) BCHE Gene;
Butyrylcholinesterase Gene =Gene or Genome
717. Bay g 6575
(UMLS (NCI) C0950386) Bay-g 6575;
=Organic Chemical; Pharmacologic Substance
767. bcl 1 gene
[The B-cell leukemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 11. ( MSH )] (UMLS (CSP) C0525036) =Gene or Genome ;
718. Bay H 2049
(UMLS (NCI) C0105296) =Organic Chemical; Pharmacologic Substance ;
768. BCL-1 Rearrangement
(UMLS (NCI) C1317175) CCND1 Gene Rearrangement;
Clonal BCL-1 Gene Rearrangement;
Clonal CCND1 Gene Rearrangement;
Monoclonal BCL-1 Gene Rearrangement =Genetic Function; ;
719. BAY I 7433
(UMLS (NCI) C0105300) =Organic Chemical; Pharmacologic Substance ;
769. BCL-2 Binding Protein
[Found only in the cytosol, TP53BP2 impedes cell cycle progression beyond G2/M. It enhances p53 trans-activation function and induces p21 (CDKN1A) expression. TP53BP2 contains ankyrin repeats and an SH3 domain, required for interaction with p53 and BCL2; TP53BP2 cannot bind both proteins simultaneously. (from OMIM 602143 and NCI) ( NCI )] (UMLS (NCI) C0290923) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
720. Bay Mills Indian Community of the Sault Ste. Marie
(UMLS (HL7) C1554231) =Population Group =NativeEntityContiguous;
770. BCL-2 Gene Family
[The BCL-2 Gene Family encodes proteins that contain Bcl-2 homology (BH) domains (1, 2, 3, or 4), involved in interactions among apoptotic protein factors that participate in programmed cell death. ( NCI )] (UMLS (NCI) C1332391) =Gene or Genome ;
721. Baycuten
(UMLS (NCI) C0053032) =Organic Chemical; Pharmacologic Substance
771. BCL1
[Essential for control of the G1/S transition, cyclin D1 interacts with CDK4 and CDK6 to form a serine/threonine kinase holoenzyme and imparts substrate specificity to the complex. RB regulates cyclin D1 gene expression. Cyclin D1 expression may identify Barrett's esophagus patients at high risk for esophageal carcinoma; risk of progression to adenocarcinoma exhibits an odds ratio of 6.85. The BCL1 and PRAD1 oncogenes involve cyclin D1 gene translocations. (from J Natl Cancer Inst 2000. 92:1282 & 1316, SWISS-PROT P24385, OMIM 168461, and NCI) ( NCI )] (UMLS (NCI) C0174680) =Amino Acid, Peptide, or Protein; Biologically Active Substance
722. Bayer 205
(UMLS (NCI) C0878170) =Organic Chemical; Pharmacologic Substance
772. BCL2 gene/protein
[over-production has been shown to make tumor cells strikingly more resistant to cell death induced by nearly all chemotherapeutic drugs and radiation, suggesting that it may be viewed as a multidrug- resistant gene. ( CSP )] (UMLS (CSP) C0872308) =Classification ;
=Cellular Oncogene;
723. Bayer Corporation
(UMLS (HL7) C1546864) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
773. BCL2-Interacting Killer Gene
[This gene is involved in the regulation of apoptosis and induces apoptotic activity. ( NCI )] (UMLS (NCI) C1332411) BIK;
BIK Gene;
=Gene or Genome ;
724. Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)
[Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) ( HL7V3.0 )] (UMLS (HL7) C1552885) =Health Care Related Organization =VaccineManufacturer;
774. BCL2-Like 1, Long Isoform
[Like bcl-2 bcl-xL acts as a repressor of apoptosis. bcl-xL mediates the closure of the mitochondrial porin channel VDAC and thus regulates the release of cytochrome c during apoptosis. ( NCI )] (UMLS (NCI) C0288330) =Amino Acid, Peptide, or Protein; Biologically Active Substance
725. bayesian calculation
[Reaching a decision through the use of Bayesian statistical analysis. ( HL7V3.0 )] (UMLS (HL7) C1553908) =Quantitative Concept =algorithm;
775. BCL2-Like 1, Short Isoform
[bcl-xS has been shown to inhibit the ability of bcl-2 and bcl-xL to enhance the survival of cells. ( NCI )] (UMLS (NCI) C0288331) =Amino Acid, Peptide, or Protein; Biologically Active Substance
726. Bayesian Method
[ ] (UMLS (CSP) C0242198) =Quantitative Concept ;
776. BCL2/Adenovirus E1B 19kd Interacting Protein 3-Like Gene
[This gene is involved in the regulation of apoptosis and induces cell death. ( NCI )] (UMLS (NCI) C1332435) BNIP3L;
BNIP3L Gene;
=Gene or Genome ;
727. BayGam
(UMLS (NCI) C0875969) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
777. BCL2L1
[A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL. ( MSH )] (UMLS (NCI) C0219472) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
728. BB 2516
(UMLS (NCI) C0663405) =Organic Chemical; Pharmacologic Substance ;
778. BCL2L1
[This gene is an apoptotic regulator that can have anti or pro apoptotic effects. ( NCI )] (UMLS (NCI) C1332397) BCL2L1 Gene;
BCL2-Like 1 Gene;
=Gene or Genome ;
729. BB-10901
[An immunoconjugate of a humanized murine monoclonal antibody (huN-901) and DMI, a semi-synthetic derivative of the plant-derived ansa macrolide maytansine. The antibody moiety of BB-10901 selectively attaches to CD56 antigen, a neural cell adhesion molecule (NCAM)) expressed on the surface of cells of small cell lung cancer (SCLC) and other neuroendocrine (NE) tumors. Thus, the DMI conjugate is targeted specifically to CD56-expressing tumor cells, where it inhibits tubulin polymerization and assembly, resulting in inhibition of mitosis and cell cycle arrest in the S phase. (NCI04) ( NCI )] (UMLS (NCI) C1328708) =Pharmacologic Substance; Immunologic Factor ;
779. BCL2L11
[This gene is involved in the regulation of apoptosis and promotes cell death. ( NCI )] (UMLS (NCI) C1337096) BCL2L11 Gene;
BCL2-like 11 (Apoptosis Facilitator) Gene;
=Gene or Genome ;
730. BB-2516/5-FU
(UMLS (NCI) C0393045) =Therapeutic or Preventive Procedure
780. BCL2L2
[This gene is involved in the regulation of apoptosis. Expression of BCL2L2 gene inhibits cellular apoptosis under cytotoxic conditions. ( NCI )] (UMLS (NCI) C1332398) BCL2L2 Gene;
BCL2-Like 2 Gene;
=Gene or Genome ;
731. BB-2516/CTX/DOX
(UMLS (NCI) C0677742) =Therapeutic or Preventive Procedure ;
781. BCNU/5-FU/IFN-A
(UMLS (NCI) C0338172) =Therapeutic or Preventive Procedure
732. BB-2516/TMX
(UMLS (NCI) C0677738) =Therapeutic or Preventive Procedure ;
782. BCNU/5-FU/SZC/VCR
(UMLS (NCI) C0796340) Carmustine/Fluorouracil/Streptozocin/Vincristine;
=Therapeutic or Preventive Procedure
733. BBB
[a physical barrier and a system of cellular transport mechanisms which maintain homeostasis in the brain by restricting the entrance of potentially harmful chemicals from the blood and by allowing the entrance of essential nutrients. ( CSP )] (UMLS (CSP) C0005854) =Body Part, Organ, or Organ Component ;
=brain;
cerebrovascular system
783. BCNU/BG
(UMLS (NCI) C0281639) =Therapeutic or Preventive Procedure
734. BBBD VIA INFUSION
[ ] (UMLS (ICD9CM) C1955622) Disruption of blood brain barrier via infusion [BBBD];
=Therapeutic or Preventive Procedure
784. BCNU/BLEO/MTX/PRED/VP-16
(UMLS (NCI) C0280434) =Therapeutic or Preventive Procedure ;
735. BBM 2478A
(UMLS (NCI) C0105343) =Organic Chemical; Antibiotic ;
785. BCNU/CBDCA/TMX
(UMLS (NCI) C0281228) =Therapeutic or Preventive Procedure ;
736. BBR 3464
[A substance that is being studied as an anticancer drug. It belongs to the family of platinum-based drugs. ( NCI )] (UMLS (NCI) C0756613) =Organic Chemical; Pharmacologic Substance
786. BCNU/CDDP
(UMLS (NCI) C0278970) =Therapeutic or Preventive Procedure
737. BC
[A country in Southern Africa, north of South Africa. (NCI) ( NCI )] (UMLS (NCI) C0006041) =Geographic Area
787. BCNU/CDDP/CTX
(UMLS (NCI) C0278671) =Therapeutic or Preventive Procedure
738. BC-2
[Encoded by human BC-2 Gene, 222-amino acid 32 kD BC-2 Protein has an unknown function and low similarity to Vps24p (S. cerevisiae). (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332383) BC-2 Protein;
Putative Breast Adenocarcinoma Marker Protein (32kD) =Amino Acid, Peptide, or Protein; Biologically Active Substance
788. BCNU/CDDP/CTX/G-CSF
(UMLS (NCI) C0280917) =Therapeutic or Preventive Procedure
739. BCAA
[Encoded by human RBBP1L1 Gene, 803-amino acid 91 kD RBP1-Like Protein is similar to RBP1, containing a Tudor domain and an ARID DNA binding domain. Different protein isoforms are thought to exist, but all have not been fully determined. Variant 2 encodes a shortened isoform 2 that lacks an internal protein fragment. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1337094) BCAA Protein;
BRCAA1 Protein;
Breast Cancer-Associated Antigen BRCAA1;
Breast Carcinoma-Associated Antigen BCAA;
KIAA0117 Protein;
Rb-Binding Protein Homolog;
RBBP1L1 Protein;
RBP1-Like Protein;
Retinoblastoma-Binding Protein 1-Like 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance
789. BCNU/CDDP/DTIC
(UMLS (NCI) C0280646) =Therapeutic or Preventive Procedure
740. BCAP
(UMLS (NCI) C1510468) BLEO/CDDP/CTX/DOX;
Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin =Therapeutic or Preventive Procedure ;
790. BCNU/CDDP/DTIC/IFN-A/IL-2/TMX
(UMLS (NCI) C0338192) =Therapeutic or Preventive Procedure ;
741. BCAR1
[This gene plays a role in signal transduction and is involved in cell adhesion, migration and proliferation. ( NCI )] (UMLS (NCI) C1366459) BCAR1 Gene;
Breast Cancer Anti-Estrogen Resistance 1 Gene =Gene or Genome ◊ [Encoded by human BCAR1 Gene, conserved ubiquitous 870-amino acid 116 kD cytoplasmic p130CAS (CAS Family) is an adaptor molecule: Ser-region, NH-SH3, central YXXP motif SH2-binding site substrate domain, SRC SH3-binding site COOH Pro-rich binding region, and C-terminal HLH. SH3 localizes CAS to focal adhesions; interacts with FAK1 P-rich region. FAK1 phosphorylates CAS YDYVHL motif. SRCs phosphorylate CAS. CAS SH2-binding sites may bind CRK, NCK, and ABL. CAS HLH may dimerize CASL. CAS Ser region promotes serum response. CAS moves to focal adhesions upon integrin triggered Y-phosphorylation. CAS complexes with CRKL and LYN. CAS functions in cardiovascular development, actin assembly, cell migration, and growth. Over expression confers breast cancer anti-estrogen resistance. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1451357) BCAR1 Protein; Breast Cancer Anti-Estrogen Resistance 1 Protein; CAS; CRKAS; CRK-Associated Substrate; p130CAS Amino Acid, Peptide, or Protein; Biologically Active Substance ;
791. BCNU/CDDP/DTIC/IFN-A/TMX
(UMLS (NCI) C0338137) =Therapeutic or Preventive Procedure
742. BCAR2
[This gene is involved in tumorigenesis. ( NCI )] (UMLS (NCI) C1332385) BCAR2 Gene;
Breast Cancer Anti-Estrogen Resistance 2 Gene =Gene or Genome ;
◊ [Encoded by human BCAR2 Gene, Breast Cancer Anti-Estrogen Resistance 2 Protein is similar to gamma-butyrobetaine 2-oxoglutarate dioxygenase (C. elegans, Drosophila) and likely responsible for development of an anti-estrogen-resistant phenotype. (from Int J Cancer. 1997; 72:700, LocusLink, GeneCard, and NCI) ( NCI )] (UMLS (NCI) C1332615) BCAR2 Protein; Breast Cancer Anti-Estrogen Resistance 2 Protein; Amino Acid, Peptide, or Protein; Biologically Active Substance
792. BCNU/CDDP/DTIC/IL-2/TMX
(UMLS (NCI) C0279124) =Therapeutic or Preventive Procedure
743. BCAR3
[Encoded by human BCAR3 Gene, the 92.6 kD 825-amino acid BCAR3 Protein contains a putative SH2 domain, a hallmark of tyrosine kinase signaling molecules, and sequences homologous to CDC48 (Yeast). Abundant expression is seen in heart, placenta, skeletal muscle, spleen, prostate, testis, ovary, small intestine, colon, fetal kidney, and several cancer cell lines, but not in nonmalignant breast tissue. NSP2 induces anti-estrogen resistance in estrogen-dependent breast tumors. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1309026) Breast Cancer Anti-Estrogen Resistance 3;
Breast Cancer Anti-Estrogen Resistance 3 Protein;
Novel SH2-Containing Protein 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ◊ [This gene plays a role in cell cycle regulation and tumorigenesis. ( NCI )] (UMLS (NCI) C1332386) BCAR3 Gene; Breast Cancer Anti-Estrogen Resistance 3 Gene Gene or Genome ;
793. BCNU/CDDP/DTIC/TMX
[A regimen consisting of tamoxifen, cisplatin, dacarbazine and carmustine used to treat advanced-stage or metastatic malignant melanoma. ( NCI )] (UMLS (NCI) C0914674) Carmustine/Cisplatin/Dacarbazine/Tamoxifen;
Dacarbazine-Cisplatin-Carmustine-Tamoxifen Regimen;
Dartmouth Regimen;
DTIC-Cisplatin-BCNU-Tamoxifen Regimen =Therapeutic or Preventive Procedure
744. BCAS1
[This gene plays a role in tumorigenesis. ( NCI )] (UMLS (NCI) C1332387) BCAS1 Gene;
Breast Carcinoma Amplified Sequence 1 Gene =Gene or Genome ;
794. BCNU/CDDP/TSPA
(UMLS (NCI) C0281356) =Therapeutic or Preventive Procedure
745. BCAS2
[This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332388) BCAS2 Gene;
Breast Carcinoma Amplified Sequence 2 Gene =Gene or Genome ;
◊ [Encoded by human BCAS2 Gene, the ubiquitous 225-amino acid DAM1 Protein contains a central putative N-glycosylation site and multiple N-terminal putative phosphorylation sites. A sequence identical to DAM1 is seen in Putative Spliceosome-Associated Protein SPF27. (from OMIM, and NCI) ( NCI )] (UMLS (NCI) C1332620) BCAS2 Protein; Breast Carcinoma Amplified Sequence 2; DAM1 Amino Acid, Peptide, or Protein; Biologically Active Substance
795. BCNU/CDDP/VP-16
(UMLS (NCI) C0278710) =Therapeutic or Preventive Procedure
746. BCAS3
[This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332389) BCAS3 Gene;
Breast Carcinoma Amplified Sequence 3 Gene =Gene or Genome ;
◊ [Encoded by human BCAS3 Gene, 913-amino acid 99.6 kD BCAS3 Protein has an unknown function. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332621) BCAS3 Protein; Breast Carcinoma Amplified Sequence 3; Amino Acid, Peptide, or Protein; Biologically Active Substance
796. BCNU/CPT-11
(UMLS (NCI) C0393059) =Therapeutic or Preventive Procedure
747. BCAS4
[This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332390) BCAS4 Gene;
Breast Carcinoma Amplified Sequence 4 Gene =Gene or Genome ;
◊ [Encoded by human BCAS4 Gene, 211-amino acid 22.8 kD BCAS4 Protein has an unknown function but high similarity to a region of MAP4K1 and similarity to metalloendopeptidase (Drosophila). BCAS4 is expressed in brain, heart, liver, pancreas, prostate, kidney, and lung. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332622) BCAS4 Protein; Breast Carcinoma Amplified Sequence 4; Amino Acid, Peptide, or Protein; Biologically Active Substance
797. BCNU/CTX/DACT/DOX/MP/MTX/PRED/VCR
(UMLS (NCI) C0278896) =Therapeutic or Preventive Procedure
748. BCD
(UMLS (NCI) C0053048) =Therapeutic or Preventive Procedure ;
798. BCNU/CTX/DACT/MP/MTX/PRED/VCR
(UMLS (NCI) C0280730) =Therapeutic or Preventive Procedure ;
749. BCDS1
[Encoded by human BCDS1 Gene, BCDS1 Protein has an unknown function and is associated with breast cancer. (from LocusLink, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1332445) BRCD1;
BRCD1 Protein;
Breast Cancer, Ductal, Suppressor-1 =Amino Acid, Peptide, or Protein; Biologically Active Substance
799. BCNU/CTX/DM
(UMLS (NCI) C0280059) =Therapeutic or Preventive Procedure
750. BCDS2
[Inactivation of tumor suppressor BCDS2 Protein, encoded by Breast Cancer, Ductal 2 Gene, may represent a fundamental step in the pathogenesis of ductal carcinoma of the breast. (OMIM, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332618) BRCD2;
Breast Cancer Suppressor-2;
Breast Cancer, Ductal 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance
800. BCNU/CTX/DOX/L-PAM
(UMLS (NCI) C0165053) =Therapeutic or Preventive Procedure ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM